Celeste McGlamery, APRN
Nurse Practitioner · Olathe, KSNPI 1326574138
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 226 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 31.2% of the total. 2025 is the largest year on record at $941, 2.2 times the $436 reported in 2021. Among nurse practitioner clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$787
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$364
- Johnson & Johnson$240
- Pfizer$159
- Lilly USA, LLC$145
- plus $632 from 15 others
What the payments were for
- Food & beverage$3,383100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 96 | $1,056 |
| Takeda Pharmaceuticals U.S.A., Inc. | 46 | $787 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 21 | $364 |
| Johnson & Johnson | 13 | $240 |
| Pfizer | 10 | $159 |
| Lilly USA, LLC | 5 | $145 |
| Regeneron Healthcare Solutions, Inc. | 6 | $122 |
| Sanofi | 4 | $71 |
| Intercept Pharmaceuticals, Inc. | 4 | $69 |
| Madrigal Pharmaceuticals | 3 | $61 |
| Merck | 4 | $58 |
| Mallinckrodt Hospital Products Inc. | 2 | $49 |
| Bristol Myers Squibb | 3 | $46 |
| Amgen | 2 | $36 |
| Daiichi Sankyo Inc. | 1 | $22 |
| Organon | 1 | $21 |
| Mylan Institutional Inc. | 1 | $19 |
| Redhill Biopharma Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,383 in reported general payments places this provider in the 90th percentile of 1,326 nurse practitioner providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 34 | $318 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Olathe
- Cheryl MyersOlathe$14K
- Jennifer LatimoreOlathe$11K
- Sara VolzOlathe$9K
- Gary GrafTopeka$726K
- Anna ShortRoeland Park$215K
- Shannon GreggTopeka$140K
- Morteza RabiiOverland Park$88K
- Constance JacobWichita$65K
- Michelle KirkHutchinson$58K
- Catherine PowellWichita$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.